Involvement of activation of PI3K/Akt pathway in the protective effects of puerarin against MPP +-induced human neuroblastoma SH-SY5Y cell death

Neurochemistry International

Volumn 60, Issue 4, 2012, Pages 400-408

  Zhu, Guoqi ^a   Wang, Xuncui ^a   Wu, Shengbing ^a   Li, Qinglin ^a  

^a ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Caspase 3; p53; PI3K Akt pathway; Puerarin

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM IODIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; CASPASE 3; IODINE DERIVATIVE; PHOSPHATIDYLINOSITOL 3 KINASE; PIFITHRIN ALPHA; PROTEIN BAX; PROTEIN P53; PUERARIN; PUMA PROTEIN; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROTECTION; CELL STRAIN SH SY5Y; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME INDUCTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; NEUROBLASTOMA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA EXTRACTION; SIGNAL TRANSDUCTION;

1-METHYL-4-PHENYLPYRIDINIUM; APOPTOSIS; BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; ENZYME ACTIVATION; HUMANS; IMMUNOHISTOCHEMISTRY; ISOFLAVONES; NEUROBLASTOMA; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84862785124     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2012.01.003     Document Type: Article

References (52)

1. Alves da Costa, C., Checler, F., 2011. Apoptosis in Parkinson's disease: is p53 the missing link between genetic and sporadic Parkinsonism? Cell. Signal. 23, 963-968.
2. Alves da Costa, C., Paitel, E., Vincent, B., Checler, F., 2002. α-Synuclein lowers p53-dependent apoptotic response of neuronal cells. J. Biol. Chem. 277, 50980-50984.
3. Bernstein, A., Garrison, S., Zambetti, G., O'Malley, K., 2011. 6-OHDA generated ROS induces DNA damage and p53- and PUMA-dependent cell death. Mol. Neurodegener. 6, 2.
4. Cheng, Y.F., Zhu, G.Q., Wang, M., Cheng, H., Zhou, A., Wang, N., Fang, N., Wang, X.C., Xiao, X.Q., Chen, Z.W., Li, Q.L., 2009. Involvement of ubiquitin proteasome system in protective mechanisms of puerarin to MPP(+)-elicited apoptosis. Neurosci. Res. 63, 52-58.
5. Cui, W., Li, W., Han, R., Mak, S., Zhang, H., Hu, S., Rong, J., Han, Y., 2011. PI3-K/Akt and ERK pathways activated by VEGF play opposite roles in MPP+induced neuronal apoptosis. Neurochem. Int. 59, 945-953.
6. D'Astous, M., Mendez, P., Morissette, M., Garcia-Segura, L.M., Di Paolo, T., 2006. Implication of the phosphatidylinositol-3 kinase/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice. Mol. Pharmacol. 69, 1492-1498.
7. Da Costa, C.A., Sunyach, C., Giaime, E., West, A., Corti, O., Brice, A., Safe, S., Abou-Sleiman, P.M., Wood, N.W., Takahashi, H., Goldberg, M.S., Shen, J., Checler, F., 2009. Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease. Nat. Cell. Biol. 11, 1370-1375.
8. Dawson, T.M., Dawson, V.L., 2003. Molecular pathways of neurodegeneration in Parkinson's disease. Science 302, 819-822. (Pubitemid 37339614)
9. Du, Y., Yang, D., Li, L., Luo, G., Li, T., Fan, X., Wang, Q., Zhang, X., Wang, Y., Le, W., 2009. An insight into the mechanistic role of p53-mediated autophagy induction in response to proteasomal inhibition-induced neurotoxicity. Autophagy 5, 663-675.
10. Duan, W., Zhu, X., Ladenheim, B., Yu, Q.-S., Guo, Z., Oyler, J., Cutler, R.G., Cadet, J.L., Greig, N.H., Mattson, M.P., 2002. P53 inhibitors preserve dopamine neurons and motor function in experimental Parkinsonism. Ann. Neurol. 52, 597-606. (Pubitemid 35246863)
11. Duke, D., Moran, L., Pearce, R., Graeber, M., 2007. The medial and lateral substantia nigra in Parkinson's disease: mRNA profiles associated with higher brain tissue vulnerability. Neurogenetics 8, 83-94. (Pubitemid 46356249)
12. Duvoisin, R.C., 1992. Overview of Parkinson's disease. Ann. NY Acad. Sci. 648, 187-193.
13. Fernandez-Gomez, F.J., Pastor, M.D., Garcia-Martinez, E.M., Melero-Fernandez de Mera, R., Gou-Fabregas, M., Gomez-Lazaro, M., Calvo, S., Soler, R.M., Galindo, M.F., Jordan, J., 2006. Pyruvate protects cerebellar granular cells from 6-hydroxydopamine-induced cytotoxicity by activating the Akt signaling pathway and increasing glutathione peroxidase expression. Neurobiol. Dis. 24, 296-307.
14. Han, R.-M., Tian, Y.-X., Becker, E.M., Andersen, M.L., Zhang, J.-P., Skibsted, L.H., 2007. Puerarin and conjugate bases as radical scavengers and antioxidants: molecular mechanism and synergism with -carotene. J. Agric. Food Chem. 55, 2384-2391. (Pubitemid 46556228)
15. Hwang, Y.P., Jeong, H.G., 2008. Mechanism of phytoestrogen puerarin-mediated cytoprotection following oxidative injury: estrogen receptor-dependent up-regulation of PI3K/Akt and HO-1. Toxicol. Appl. Pharmacol. 233, 371-381.
16. Jiang, B., Liu, J.H., Bao, Y.M., An, L.J., 2003. Hydrogen peroxide-induced apoptosis in pc12 cells and the protective effect of puerarin. Cell Biol. Int. 27, 1025-1031. (Pubitemid 37463535)
17. Karunakaran, S., Saeed, U., Mishra, M., Valli, R.K., Joshi, S.D., Meka, D.P., Seth, P., Ravindranath, V., 2008. Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-treated mice. J. Neurosci. 28, 12500-12509.
18. Kaytor, M.D., Orr, H.T., 2002. The GSK3 beta signaling cascade and neurodegenerative disease. Curr. Opin. Neurobiol. 12, 275-278. (Pubitemid 34615752)
19. Kim, S.N., Kim, S.T., Doo, A.R., Park, J.Y., Moon, W., Chae, Y., Yin, C.S., Lee, H., Park, H.J., 2011. Phosphatidylinositol 3-kinase/Akt signaling pathway mediates acupuncture-induced dopaminergic neuron protection and motor function improvement in a mouse model of Parkinson's disease. Int. J. Neurosci. 121, 562-569.
20. Kong, D., Zhang, Y., Yamori, T., Duan, H., Jin, M., 2011. Inhibitory activity of flavonoids against class I phosphatidylinositol 3-kinase isoforms. Molecules 16, 5159-5167.
21. Lee, E.S., Yin, Z., Milatovic, D., Jiang, H., Aschner, M., 2009. Estrogen and tamoxifen protect against Mn-induced toxicity in rat cortical primary cultures of neurons and astrocytes. Toxicol. Sci. 110, 156-167.
22. Li, X., Sun, S., Tong, E., 2003. Experimental study on the protective effect of puerarin to Parkinson disease. J. Huazhong Univ. Sci. Technolog. Med. Sci. 23, 148-150. (Pubitemid 41559742)
23. Liang, S.H., Clarke, M.F., 2001. Regulation of p53 localization. Eur. J. Biochem. 268, 2779-2783. (Pubitemid 32862959)
24. Lim, J.H., Kim, S.S., Boo, D.H., No, H., Kang, B.Y., Kim, E.M., Hwang, O., Choi, H.J., 2009. Protective effect of bromocriptine against BH4-induced Cath.a cell death involving up-regulation of antioxidant enzymes. Neurosci. Lett. 451, 185-189.
25. Liu, G., Chen, X., 2006. Regulation of the p53 transcriptional activity. J. Cell Biochem. 97, 448-458. (Pubitemid 43265305)
26. Macip, S., Igarashi, M., Berggren, P., Yu, J., Lee, S.W., Aaronson, S.A., 2003. Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol. Cell. Biol. 23, 8576-8585. (Pubitemid 37433363)
27. Mandir, A.S., Simbulan-Rosenthal, C.M., Poitras, M.F., Lumpkin, J.R., Dawson, V.L., Smulson, M.E., Dawson, T.M., 2002. A novel in vivo post-translational modification of p53 by PARP-1 in MPTP-induced Parkinsonism. J. Neurochem. 83, 186-192.
28. Mercer, L.D., Kelly, B.L., Horne, M.K., Beart, P.M., 2005. Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures. Biochem. Pharmacol. 69, 339-345. (Pubitemid 41556580)
29. Mogi, M., Kondo, T., Mizuno, Y., Nagatsu, T., 2007. P53 protein, interferon-[gamma], and NF-[kappa]B levels are elevated in the Parkinsonian brain. Neurosci. Lett. 414, 94-97. (Pubitemid 46241643)
30. Nagley, P., Higgins, G.C., Atkin, J.D., Beart, P.M., 2010. Multifaceted deaths orchestrated by mitochondria in neurones. Biochim. Biophys. Acta 1802, 167-185.
31. Nair, V.D., McNaught, K.S., Gonzalez-Maeso, J., Sealfon, S.C., Olanow, C.W., 2006. P53 mediates nontranscriptional cell death in dopaminergic cells in response to proteasome inhibition. J. Biol. Chem. 281, 39550-39560. (Pubitemid 46041915)
32. Nakaso, K., Ito, S., Nakashima, K., 2008. Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells. Neurosci. Lett. 432, 146-150.
33. Noelker, C., Bacher, M., Gocke, P., Wei, X., Klockgether, T., Du, Y., Dodel, R., 2005. The flavanoide caffeic acid phenethyl ester blocks 6-hydroxydopamine-induced neurotoxicity. Neurosci. Lett. 383, 39-43. (Pubitemid 40779951)
34. Offen, D., Beart, P.M., Cheung, N.S., Pascoe, C.J., Hochman, A., Gorodin, S., Melamed, E., Bernard, R., Bernard, O., 1998. Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Proc. Natl. Acad. Sci. USA 95, 5789-5794. (Pubitemid 28224175)
35. Perier, C., Bove, J., Wu, D.C., Dehay, B., Choi, D.K., Jackson-Lewis, V., Rathke-Hartlieb, S., Bouillet, P., Strasser, A., Schulz, J.B., Przedborski, S., Vila, M., 2007. Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease. Proc. Natl. Acad. Sci. USA 104, 8161-8166. (Pubitemid 47185892)
36. Proctor, C.J., Gray, D.A., 2011. GSK3 and p53 - is there a link in Alzheimer's disease? Mol. Neurodegener. 5, 7.
37. Rieker, C., Engblom, D., Kreiner, G., Domanskyi, A., Schober, A., Stotz, S., Neumann, M., Yuan, X., Grummt, I., Schutz, G., Parlato, R., 2011. Nucleolar disruption in dopaminergic neurons leads to oxidative damage and Parkinsonism through repression of mammalian target of rapamycin signaling. J. Neurosci. 31, 453-460.
38. Shang, T., Kotamraju, S., Zhao, H., Kalivendi, S.V., Hillard, C.J., Kalyanaraman, B., 2005. Sepiapterin attenuates 1-methyl-4-phenylpyridinium- induced apoptosis in neuroblastoma cells transfected with neuronal NOS: role of tetrahydrobiopterin, nitric oxide, and proteasome activation. Free Radic. Biol. Med. 39, 1059-1074. (Pubitemid 41356597)
39. Shim, J.S., Kim, H.G., Ju, M.S., Choi, J.G., Jeong, S.Y., Oh, M.S., 2009. Effects of the hook of Uncaria rhynchophylla on neurotoxicity in the 6-hydroxydopamine model of Parkinson's disease. J. Ethnopharmacol. 126, 361-365.
40. Sugano, T., Yanagita, T., Yokoo, H., Satoh, S., Kobayashi, H., Wada, A., 2006. Enhancement of insulin-induced PI3K/Akt/GSK-3beta and ERK signaling by neuronal nicotinic receptor/PKC-alpha/ERK pathway: up-regulation of IRS-1/-2 mRNA and protein in adrenal chromaffin cells. J. Neurochem. 98, 20-33. (Pubitemid 43882929)
41. Tasaki, Y., Omura, T., Yamada, T., Ohkubo, T., Suno, M., Iida, S., Sakaguchi, T., Asari, M., Shimizu, K., Matsubara, K., 2011. Meloxicam protects cell damage from 1-methyl-4-phenyl pyridinium toxicity via the phosphatidylinositol 3-kinase/Akt pathway in human dopaminergic neuroblastoma SH-SY5Y cells. Brain Res. 1344, 25-33.
42. Wang, G., Zhou, L., Zhang, Y., Dong, M., Li, X., Liu, J., Niu, Y., 2011a. Implication of the c-Jun-NH2-terminal kinase pathway in the neuroprotective effect of puerarin against 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in PC-12 cells. Neurosci. Lett. 487, 88-93.
43. +-induced apoptosis by AKT/GSK-3β/JNK signaling. Apoptosis 15, 1470-1479.
44. Watcharasit, P., Bijur, G.N., Zmijewski, J.W., Song, L., Zmijewska, A., Chen, X., Johnson, G.V.W., Jope, R.S., 2002. Direct, activating interaction between glycogen synthase kinase-3β and p53 after DNA damage. Proc. Natl. Acad. Sci. USA 99, 7951-7955. (Pubitemid 34650986)
45. Wen, Y., Li, W., Poteet, E.C., Xie, L., Tan, C., Yan, L.-J., Ju, X., Liu, R., Qian, H., Marvin, M.A., Goldberg, M.S., She, H., Mao, Z., Simpkins, J.W., Yang, S.-H., 2011. Alternative mitochondrial electron transfer as a novel strategy for neuroprotection. J. Biol. Chem. 286, 16504-16515.
46. Weng, C.J., Chen, M.J., Yeh, C.T., Yen, G.C., 2011. Hepatoprotection of quercetin against oxidative stress by induction of metallothionein expression through activating MAPK and PI3K pathways and enhancing Nrf2 DNA-binding activity. N. Biotechnol. 28, 767-777.
47. Wu, Y., Shang, Y., Sun, S., Liu, R., 2007. Antioxidant effect of erythropoietin on 1-methyl-4-phenylpyridinium-induced neurotoxicity in PC12 cells. Eur. J. Pharmacol. 564, 47-56. (Pubitemid 46946850)
48. Xing, G., Dong, M., Li, X., Zou, Y., Fan, L., Wang, X., Cai, D., Li, C., Zhou, L., Liu, J., Niu, Y., 2011. Neuroprotective effects of puerarin against beta-amyloid-induced neurotoxicity in PC12 cells via a PI3K-dependent signaling pathway. Brain Res. Bull. 85, 212-218.
49. Xu, X.H., Zheng, X.X., Zhou, Q., Li, H., 2007. Inhibition of excitatory amino acid efflux contributes to protective effects of puerarin against cerebral ischemia in rats. Biomed. Environ. Sci. 20, 336-342. (Pubitemid 47441814)
50. Yasuda, T., Hayakawa, H., Nihira, T., Ren, Y.R., Nakata, Y., Nagai, M., Hattori, N., Miyake, K., Takada, M., Shimada, T., Mizuno, Y., Mochizuki, H., 2011. Parkin-mediated protection of dopaminergic neurons in a chronic MPTP-minipump mouse model of Parkinson disease. J. Neuropathol. Exp. Neurol. 70, 686-697.
51. Zhang, H.Y., Liu, Y.H., Wang, H.Q., Xu, J.H., Hu, H.T., 2008. Puerarin protects PC12 cells against beta-amyloid-induced cell injury. Cell Biol. Int. 32, 1230-1237.
52. Zhu, G., Wang, X., Chen, Y., Yang, S., Cheng, H., Wang, N., Li, Q., 2010. Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of Parkinson's disease. Planta Med. 76, 1820-1826.